Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Harvard Business School
Johnson and Johnson
Boehringer Ingelheim
Merck
Express Scripts
Medtronic

Last Updated: December 5, 2019

DrugPatentWatch Database Preview

Cefuroxime axetil - Generic Drug Details

See Plans and Pricing

« Back to Dashboard

What are the generic drug sources for cefuroxime axetil and what is the scope of patent protection?

Cefuroxime axetil is the generic ingredient in two branded drugs marketed by Glaxosmithkline, Sun Pharm Inds Ltd, Alkem Labs Ltd, Ani Pharms Inc, Apotex, Aurobindo Pharma Ltd, Fosun Pharma, Lupin, Orchid Hlthcare, Ranbaxy Labs Ltd, and Wockhardt, and is included in thirteen NDAs. Additional information is available in the individual branded drug profile pages.

There are sixty-two drug master file entries for cefuroxime axetil. Sixteen suppliers are listed for this compound.

Drug Prices for cefuroxime axetil

See drug prices for cefuroxime axetil

Drug Sales Revenue Trends for cefuroxime axetil

See drug sales revenues for cefuroxime axetil

Recent Clinical Trials for cefuroxime axetil

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of LouisvillePhase 0
Julio RamirezPhase 0
James Graham Brown Cancer CenterPhase 0

See all cefuroxime axetil clinical trials

Pharmacology for cefuroxime axetil
Synonyms for cefuroxime axetil
(+/-)-Cefuroxime axetil, (E)-
(1RS)-1-(Acetyloxy)ethyl (6R,7R)-3-((carbamoyloxy)methyl)-7-(((E)-2-(furan-2-yl)-2-(methoxyimino)acetyl)amino)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2carboxylate
(6R,7R)-1-acetoxyethyl 3-(carbamoyloxymethyl)-7-((Z)-2-(furan-2-yl)-2-(methoxyimino)acetamido)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
(6R,7R)-3-(carbamoyloxymethyl)-7-[[(2Z)-2-(2-furanyl)-2-methoxyimino-1-oxoethyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid 1-acetyloxyethyl ester
(6r,7r)-3-[[(aminocarbonyl)oxy]methyl]-7-[[(2e)-2-(2-furanyl)-2-(methoxyimino)-1-oxoethyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxyli
(6R,7R)-3-[[(Aminocarbonyl)oxy]methyl]-7-[[(2E)-2-(2-furanyl)-2-(methoxyimino)acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid 1-(Acetyloxy)ethyl Ester
(6R,7R)-3-[[(Aminocarbonyl)oxy]methyl]-7-[[(2Z)-2-(2-furanyl)-2-(methoxyimino)acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid 1-(Acetyloxy)ethyl Ester
(E)-Cefuroxime Axetil
(RS)-1-Hydroxyethyl (6R,7R)-7-(2-(2-furyl)glyoxylamido)-3-(hydroxymethyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate, 7(sup 2)-(Z)-(O-methyloxime), 1-acetate 3-carbamate
1-(acetyloxy)ethyl (6R,7R)-3-{[(aminocarbonyl)oxy]methyl}-7-({(2E)-2-furan-2-yl-2-[(methyloxy)imino]acetyl}amino)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
1-(acetyloxy)ethyl(6r,7r)-3-[(carbamoyloxy)methyl]-7-{[furan-2-yl(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
1-acetoxyethyl (6R,7R)-3-(carbamoyloxymethyl)-7-[[(2Z)-2-(2-furyl)-2-methoxyimino-acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
1-Acetoxyethyl (6R,7R)-3-carbamoyloxymethyl-7-[(Z)-2-(fur-2-yl)-2-methoxyiminoacetamido]ceph-3-em-4-carboxylate
1-acetyloxyethyl (6R,7R)-3-(aminocarbonyloxymethyl)-7-[[(2Z)-2-(furan-2-yl)-2-methoxyimino-ethanoyl]amino]-8-oxidanylidene-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
1-acetyloxyethyl (6R,7R)-3-(carbamoyloxymethyl)-7-[[(2E)-2-(furan-2-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
1-acetyloxyethyl (6R,7R)-3-(carbamoyloxymethyl)-7-[[(2Z)-2-(furan-2-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
1-acetyloxyethyl (6R,7R)-3-(carbamoyloxymethyl)-7-[[2-(furan-2-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
1-acetyloxyethyl 3-(carbamoyloxymethyl)-7-[[(2Z)-2-(furan-2-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
1-acetyloxyethyl 3-(carbamoyloxymethyl)-7-[[2-(furan-2-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 3-(((aminocarbonyl)oxy)methyl)-7-(((2E)-2-(2-furanyl)-2-(methoxyimino)acetyl)amino)-8-oxo-, 1-(acetyloxy)ethyl ester, (6R,7R)-
5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 3-(((aminocarbonyl)oxy)methyl)-7-((2-furanyl(methoxyimino)acetyl)amino)-8-oxo-, 1-(acetyloxy)ethyl ester, (6R-(6alpha,7beta(E)))-
5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 3-(((aminocarbonyl)oxy)methyl)-7-((2-furanyl(methoxyimino)acetyl)amino)-8-oxo-, 1-(acetyloxy)ethyl ester, (6R-(6alpha,7beta(Z)))-
544C076
64544-07-6
97232-96-7
A834806
AB00053386_02
AC1L2I23
AC1MP5LV
AC1NSF88
AC1NXLB3
AC1O426M
AC1Q6LOH
AKOS015896220
AKOS015966892
AKOS030242591
Altacef
AN-38773
anti-Cefloxime axetil
API0001920
AS-14135
AT-20730
BCP10740
Bioracef
BRD-A36322567-001-01-6
BRN 6854419
C08107
C20H22N4O10S
CC0151
CCG-213274
CCG-221241
CCI 1564
CCI 15641
CCI-15641
Cefaks
Cefazine
Ceftin
Cefuroximaxetil
Cefuroxime 1-acetoxyethyl ester
Cefuroxime axetil (JP17/USP/INN)
Cefuroxime axetil [USAN:BAN:JAN]
Cefuroxime axetil [USAN:USP:BAN:JAN]
Cefuroxime axetil impurity B [EP]
Cefuroxime axetil specified impurity B [EP]
Cefuroxime axetil, (E)-
Cefuroxime Axetil, European Pharmacopoeia (EP) Reference Standard
Cefuroxime Axetil, mixture of isomers, analytical standard
Cefuroxime Axetil, United States Pharmacopeia (USP) Reference Standard
Cefuroxime Axetil,(S)
Celocid
Cepazine
Cethixim
Cetoxil
CHEBI:3516
CHEMBL1095930
Coliofossim
CTK8F8544
CXM-AX
D00914
DivK1c_006829
DRG-0157
DTXSID0022775
DTXSID20242788
Elobact
Forcef
Furoxime
HMS2093A20
HMS3715J04
HSDB 8150
I06-1564
K039
Kalcef
KBio1_001773
KEJCWVGMRLCZQQ-YJBYXUATSA-N
LS-149935
Maxitil
Medoxm
MolPort-003-666-792
MolPort-005-935-571
Nivador
NSC-758677
NSC758677
Pharmakon1600-01504175
SCHEMBL379336
SCHEMBL41099
SCHEMBL6859269
SCHEMBL721709
Sharox-500
SN 407
SN-407
SpecPlus_000733
SR-05000001889
SR-05000001889-1
UNII-XSL6I3SB26
UNII-Z49QDT0J8Z
VA10549
XSL6I3SB26
Z49QDT0J8Z
Zinat
Zinnat
Zoref

US Patents and Regulatory Information for cefuroxime axetil

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ani Pharms Inc CEFUROXIME AXETIL cefuroxime axetil TABLET;ORAL 065190-001 Oct 18, 2004 AB RX No No   Start Trial   Start Trial   Start Trial
Orchid Hlthcare CEFUROXIME AXETIL cefuroxime axetil TABLET;ORAL 065359-003 Feb 15, 2008 AB RX No No   Start Trial   Start Trial   Start Trial
Ani Pharms Inc CEFUROXIME AXETIL cefuroxime axetil TABLET;ORAL 065190-002 Oct 18, 2004 AB RX No No   Start Trial   Start Trial   Start Trial
Wockhardt CEFUROXIME AXETIL cefuroxime axetil TABLET;ORAL 065166-003 Jul 29, 2005 AB RX No No   Start Trial   Start Trial   Start Trial
Sun Pharm Inds Ltd CEFUROXIME AXETIL cefuroxime axetil TABLET;ORAL 065118-003 Apr 25, 2003 DISCN No No   Start Trial   Start Trial   Start Trial
Glaxosmithkline CEFTIN cefuroxime axetil TABLET;ORAL 050605-002 Dec 28, 1987 DISCN Yes No   Start Trial   Start Trial   Start Trial
Orchid Hlthcare CEFUROXIME AXETIL cefuroxime axetil TABLET;ORAL 065359-001 Feb 15, 2008 AB RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Johnson and Johnson
Express Scripts
Medtronic
Harvard Business School
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.